文献速递神经肌肉病

RCC1双等位基因变异儿童感染后急性轴索性神经病病例系列

Acute-onset axonal neuropathy following infection in children with biallelic RCC1 variants: a case series.
PubMed 文献 · Lancet Neurol · 2025-01-01

该病例系列通过九国儿科神经科与临床遗传学联盟识别出12个家系24例感染后严重急性轴索性神经病患儿,均携带RCC1双等位基因错义变异,呈常染色体隐性遗传。表型从快速进展致死性轴索性神经病到轻度运动神经病不等,15例死亡、15例复发,部分初诊被误判为吉兰-巴雷综合征。

要点

  • 感染后急性轴索性神经病患儿应警惕RCC1双等位基因变异,可模拟吉兰-巴雷综合征。
  • 该病呈常染色体隐性遗传,表型谱广,可出现复发并致死。
  • RCC1变异影响核质运输,应激下功能缺陷可能是病理机制。

核心结论

  • 感染后急性起病的儿童轴索性神经病可见于携带RCC1双等位基因变异者,呈常染色体隐性遗传,临床可模拟吉兰-巴雷综合征。
  • RCC1变异影响GDP-to-GTP交换活性与热稳定性,应激下核质运输缺陷可能参与致病。

研究设计与样本

  • 多国儿科神经科与临床遗传学联盟开展的病例系列,来自九个国家。
  • 纳入2011年11月2日至2024年7月10日识别的24例患儿(12个家系,13女11男,诊断平均年龄1岁10个月[SD 2·27])。
  • 对全部患者DNA行外显子或基因组测序,并用重组蛋白热稳定性和酶学测定、患者原代成纤维细胞免疫荧光及人源化果蝇敲入模型进行功能研究。

主要发现

  • 共识别8个RCC1双等位基因错义变异,呈常染色体隐性遗传。
  • 表型从快速进展致死性轴索性神经病到轻度运动神经病伴行走障碍不等。
  • 神经系统表现常继发于感染,部分患者初诊误判为吉兰-巴雷综合征;15例复发,15例死亡。
  • 患者变异编码蛋白改变GDP-to-GTP交换活性且体外热稳定性降低;热休克或氧化应激下成纤维细胞显示Ran核定位缺陷和核质运输受损。
  • 果蝇模型显示对氧化应激存在致死性不耐受。

临床怎么用

  • 对感染后急性起病的儿童严重轴索性神经病,尤其有复发或家族史者,应考虑RCC1相关遗传病并避免仅按吉兰-巴雷综合征处理。
  • 诊断可结合临床、神经传导与神经影像,并通过外显子或基因组测序确认RCC1双等位基因变异。
  • 研究中提示未来可探索维持核质运输的症状前治疗方向。

局限性

  • 为病例系列,未设对照,不能估计患病率或疗效。
  • 功能机制证据主要来自体外重组蛋白、患者成纤维细胞和果蝇模型,人体内验证有限。
  • 原文未报告具体治疗干预及随访结局数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The reasons why some individuals have severe neuropathy following an infection are not known. Through the agnostic screening of children with acute axonal neuropathy after an infection, we identified several families with biallelic variants in RCC1. We aimed to describe the clinical phenotype of these patients, and the molecular and cellular pathology associated with the genetic variants identified in these families. METHODS: For this case series, we identified children affected by a severe, acute-onset axonal neuropathy following infection through an international research consortium of paediatric neurologists and clinical geneticists from nine countries (Canada, Cyprus, Czechia, Germany, Iran, Saudi Arabia, Slovakia, Türkiye, and the UK). Clinical assessments included nerve conduction studies and neuroimaging. We did exome or genome sequencing in DNA samples from all patients. We characterised the proteins encoded by the genetic variants by use of thermal stability and enzymatic assays, using recombinantly expressed proteins. We assessed cellular protein transport under heat or oxidative stress by use of immunofluorescence in primary fibroblasts, obtained from patients. We generated a humanised Drosophila knock-in model to assess the effects of stress on the in vivo function of RCC1. FINDINGS: Between Nov 2, 2011, and July 10, 2024, we identified 24 individuals from 12 families who had severe, acute-onset axonal neuropathy following infection (13 female and 11 male patients, with a mean age at diagnosis of 1 year 10 months [SD 2·27]). Eight biallelic missense variants in RCC1 were identified in affected individuals with autosomal recessive inheritance. Patients had variable phenotypes, ranging from rapidly progressive fatal axonal neuropathy to mild motor neuropathy with impaired walking. Neurological presentation was often secondary to an infection, resulting in initial misdiagnoses of Guillain-Barré syndrome in several patients. 15 children had disease recurrence. The disease was fatal in 15 patients. The RCC1 variants in these patients code for proteins that alter GDP-to-GTP exchange activity and have reduced thermal stability in vitro. In primary fibroblasts, heat shock or oxidative stress revealed defects in Ran nuclear localisation and impaired nucleocytoplasmic transport. A Drosophila model of the disease revealed a fatal intolerance to oxidative stress. INTERPRETATION: We describe an autosomal recessive, acute-onset paediatric axonal neuropathy, seemingly triggered by infection, that affects individuals with biallelic RCC1 variants. In these children, the disease can mimic Guillain-Barré syndrome. The pathological mechanisms underlying this novel axonal neuropathy might overlap with those of amyotrophic lateral sclerosis. Cellular studies indicate that RCC1 variants affect nucleocytoplasmic transport, which is crucial for healthy axonal function. Future studies should be directed at pre-symptomatic treatment by exploring ways to maintain nucleocytoplasmic transport. FUNDING: National Institute for Health and Care Research, LifeArc, and Wellcome Trust.

来源:Lancet Neurol,查看原文。版权归原作者所有。

引用

  1. Harkness JR, McDermott JH, Marsden S, et al. Acute-onset axonal neuropathy following infection in children with biallelic RCC1 variants: a case series. Lancet Neurol. 2025. PMID: 40683276. doi:10.1016/S1474-4422(25)00198-X

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。